277 related articles for article (PubMed ID: 22854890)
1. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
[TBL] [Abstract][Full Text] [Related]
2. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy.
Kostovska I; Trajkovska KT; Cekovska S; Topuzovska S; Kavrakova JB; Spasovski G; Kostovski O; Labudovic D
Rom J Intern Med; 2020 Dec; 58(4):233-241. PubMed ID: 32780718
[No Abstract] [Full Text] [Related]
3. Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes.
Shoji M; Kobayashi K; Takemoto M; Sato Y; Yokote K
Biomarkers; 2016; 21(2):164-7. PubMed ID: 26635084
[TBL] [Abstract][Full Text] [Related]
4. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli.
Hara M; Yanagihara T; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Kihara I
Hum Pathol; 2010 Sep; 41(9):1265-75. PubMed ID: 20447677
[TBL] [Abstract][Full Text] [Related]
5. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
[TBL] [Abstract][Full Text] [Related]
6. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
7. Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.
Suwanpen C; Nouanthong P; Jaruvongvanich V; Pongpirul K; Pongpirul WA; Leelahavanichkul A; Kanjanabuch T
J Nephrol; 2016 Feb; 29(1):37-44. PubMed ID: 25905599
[TBL] [Abstract][Full Text] [Related]
8. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.
Akankwasa G; Jianhua L; Guixue C; Changjuan A; Xiaosong Q
Biomark Med; 2018 Aug; 12(8):927-935. PubMed ID: 29976076
[TBL] [Abstract][Full Text] [Related]
9. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
10. Urinary sediment podocalyxin in children with glomerular diseases.
Kanno K; Kawachi H; Uchida Y; Hara M; Shimizu F; Uchiyama M
Nephron Clin Pract; 2003; 95(3):c91-9. PubMed ID: 14646369
[TBL] [Abstract][Full Text] [Related]
11. Urinary podocalyxin as a possible novel marker of intrauterine nephrogenesis and extrauterine podocyte injury.
Hayashi T; Tokuriki S; Okuno T; Ohta G; Igarashi A; Ohshima Y
Pediatr Nephrol; 2017 Oct; 32(10):1891-1896. PubMed ID: 28439668
[TBL] [Abstract][Full Text] [Related]
12. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
Ma RX; Zhao N; Zhang W
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
[TBL] [Abstract][Full Text] [Related]
13. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
[TBL] [Abstract][Full Text] [Related]
14. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury.
Hara M; Yanagihara T; Kihara I; Higashi K; Fujimoto K; Kajita T
J Am Soc Nephrol; 2005 Feb; 16(2):408-16. PubMed ID: 15625073
[TBL] [Abstract][Full Text] [Related]
15. Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy.
Fayed A; Rahman Tohamy IA; Kahla H; Elsayed NM; El Ansary M; Saadi G
Diabetes Metab Syndr; 2019; 13(5):2849-2854. PubMed ID: 31425946
[TBL] [Abstract][Full Text] [Related]
16. [Research on the Combined Detection of Urine UmAlb and Urinary Nephrin, Podocalyxin in Podocyte of MKR Mice with Diabetic Nephropathy].
Zeng J; Zhang X; Yu R; Tang Y; Luo WJ; Chen C; Wu YJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):722-5. PubMed ID: 26619543
[TBL] [Abstract][Full Text] [Related]
17. The Podocyte Count Detected by an Improved Immunocytochemical Method has Higher Diagnostic Efficiency than Enzyme-Linked Immunosorbent Assay and Serum Cystatin C to Evaluate the Early Stage Damage of Glomerular.
Li L; Wang J; Li Y; Lu C; Liu Y; Zhang Z; Wang ZE; Zhang J; Lu Z
J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27435507
[TBL] [Abstract][Full Text] [Related]
18. [Urinary podocyte and urinary podocalyxin; markers for diabetic nephropathy].
Takemoto M; Shoji M; Yokote K
Nihon Rinsho; 2016 Apr; 74 Suppl 2():181-5. PubMed ID: 27266084
[No Abstract] [Full Text] [Related]
19. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis.
Hara M; Yamamoto T; Yanagihara T; Takada T; Itoh M; Adachi Y; Yoshizumi A; Kawasaki K; Kihara I
Nephron; 1995; 69(4):397-403. PubMed ID: 7777103
[TBL] [Abstract][Full Text] [Related]
20. Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.
Lioudaki E; Stylianou KG; Petrakis I; Kokologiannakis G; Passam A; Mikhailidis DP; Daphnis EK; Ganotakis ES
Nephron; 2015; 131(1):34-42. PubMed ID: 26340089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
